Relos, Dyesebel .
HRN: 26-20-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
CEFTRIAXONE 1G (VIAL)
11/15/2024
11/22/2024
IV
2 Grams
OD
Dengue Fever With Warning Signs
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes